曲古抑菌素A膀胱灌注对大鼠膀胱癌生长的抑制作用

李功成, 潘铁军, 田雨冬, 等. 曲古抑菌素A膀胱灌注对大鼠膀胱癌生长的抑制作用[J]. 临床泌尿外科杂志, 2013, 28(2): 148-151.
引用本文: 李功成, 潘铁军, 田雨冬, 等. 曲古抑菌素A膀胱灌注对大鼠膀胱癌生长的抑制作用[J]. 临床泌尿外科杂志, 2013, 28(2): 148-151.
LI Gongcheng, PAN Tiejun, TIAN Yudong, et al. Inhibitory effect of intravesical instillation of trichostatin A in rats with bladder cancer[J]. J Clin Urol, 2013, 28(2): 148-151.
Citation: LI Gongcheng, PAN Tiejun, TIAN Yudong, et al. Inhibitory effect of intravesical instillation of trichostatin A in rats with bladder cancer[J]. J Clin Urol, 2013, 28(2): 148-151.

曲古抑菌素A膀胱灌注对大鼠膀胱癌生长的抑制作用

详细信息
    通讯作者: 潘铁军,E-mail:mwkptj@yahoo.com.cn
  • 中图分类号: R737.14

Inhibitory effect of intravesical instillation of trichostatin A in rats with bladder cancer

More Information
  • 目的:探讨曲古抑菌素A(TSA)膀胱灌注对大鼠膀胱肿瘤生长的抑制作用和机制。方法:将42只雌性Wistar大鼠,随机分为对照组和TSA组,制作MNU诱导大鼠原位膀胱癌模型,在第10周分别行生理盐水和TSA连续膀胱灌注,每周1次,共7次。分别在灌注的第l2周和17周进行病理观察、测量膀胱总重量、凋亡指数及western blot检测。结果:与对照组相比,TSA组大鼠膀胱肿瘤小且单发较多。TSA组大鼠膀胱的重量小于对照组(P<0.05);TSA组大鼠膀胱肿瘤的凋亡指数大于对照组(P<0.01),TSA组大鼠膀胱肿瘤组织XIAP的表达较对照组明显降低。结论:TSA膀胱灌注可抑制大鼠膀胱肿瘤生长,延缓肿瘤进展,其机制与诱导肿瘤细胞凋亡有关,并可能涉及相关基因XIAP表达的调控。
  • 加载中
  • [1]

    Hara I, Miyake H, Takechi Y, et al. Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder[J]. Int J Urol, 2003, 10:19-24.

    [2]

    Li G C, Zhang X, Pan T J, et al. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest[J]. Int J Urol, 2006,13:581-586.

    [3]

    Wetzel M, Premkumar D R, Arnold B, et al. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by induding cell cycle arrest and apoptosis[J]. J Neurosung, 2005, 103:549-556.

    [4]

    Yaman O, Ozdiler E, Sozen S, et al. Transmurally absorbed intravesical Chemotherapy with dimethylsulfoxide in an animal model[J]. Int J Urol, 1999, 6:87-92.

    [5]

    Hess-stumpp H. Histone deacetylase inhibitors and cancer:from cell biology to the clinic[J]. Eur J Cell Biol, 2005, 84:109-121.

    [6]

    Richon V M, Obrien J P. Histone deacetylase inhibitors:a new class of potential therapeutic agents for cancer treatment[J]. Clin Cancer Res, 2002, 8:662-664.

    [7]

    Minucci S, Pelicci P G. Histone deacetylase inhibitors and the promise of epigenetic(and more)treatments for cancer[J]. Nat Rev Cancer, 2006, 6:38-51.

    [8]

    Fishel M L, Newell D R, Griffin R J, et al. Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity[J]. J Pharmacol Exp Ther, 2005, 312:206-213.

    [9]

    McKnight J J, Gray S B, O'Kane H F, et al. Apoptosis and chemotherapy for bladder cancer[J]. J Urol, 2005, 173:683-690.

    [10]

    Scott F L, Denault J B, Riedl S J, et al. XIAP inhibits caspase-3 and -7 using two binding sites:evolutionarily conserved mechanism of IAPs[J]. EMBO J, 2005, 24:645-655.

    [11]

    Tamm I, Kornblau S M, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and mye1oid leukemias[J]. Clin Cancer Res, 2000, 6:1796-1803.

    [12]

    Korga A, Korobowicz E, Dudka J. Role of mitochondrial protein Smac/Diablo in regulation of apoptotic pathways[J]. Pol Merkur Lekarski, 2006, 20:573-576.

  • 加载中
计量
  • 文章访问数:  77
  • PDF下载数:  68
  • 施引文献:  0
出版历程
收稿日期:  2012-07-21

目录